Authors:
KENT SJ
ZHAO A
BEST SJ
CHANDLER JD
BOYLE DB
RAMSHAW IA
Citation: Sj. Kent et al., ENHANCED T-CELL IMMUNOGENICITY AND PROTECTIVE EFFICACY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VACCINE REGIMEN CONSISTING OF CONSECUTIVE PRIMING WITH DNA AND BOOSTING WITH RECOMBINANT FOWLPOX VIRUS, Journal of virology (Print), 72(12), 1998, pp. 10180-10188
Authors:
HEINE HG
FOORD AJ
YOUNG PL
HOOPER PT
LEHRBACH PR
BOYLE DB
Citation: Hg. Heine et al., RECOMBINANT FOWLPOX VIRUS-VACCINES AGAINST AUSTRALIAN VIRULENT MAREKS-DISEASE VIRUS - GENE SEQUENCE-ANALYSIS AND COMPARISON OF VACCINE EFFICACY IN SPECIFIC PATHOGEN-FREE AND PRODUCTION CHICKENS, Virus research, 50(1), 1997, pp. 23-33
Authors:
ROTHEL JS
BOYLE DB
BOTH GW
PYE AD
WATERKEYN JG
WOOD PR
LIGHTOWLERS MW
Citation: Js. Rothel et al., SEQUENTIAL NUCLEIC-ACID AND RECOMBINANT ADENOVIRUS VACCINATION INDUCES HOST-PROTECTIVE IMMUNE-RESPONSES AGAINST TAENIA-OVIS INFECTION IN SHEEP, Parasite immunology, 19(5), 1997, pp. 221-227
Citation: C. Hertig et al., FIELD AND VACCINE STRAINS OF FOWLPOX VIRUS CARRY INTEGRATED SEQUENCESFROM THE AVIAN RETROVIRUS, RETICULOENDOTHELIOSIS VIRUS, Virology, 235(2), 1997, pp. 367-376
Citation: Zz. Xu et al., CONSTRUCTION OF OVINE ADENOVIRUS RECOMBINANTS BY GENE INSERTION OR DELETION OF RELATED TERMINAL REGION SEQUENCES, Virology, 230(1), 1997, pp. 62-71
Citation: S. Vrati et al., NUCLEOTIDE-SEQUENCE OF OVINE ADENOVIRUS TRIPARTITE LEADER SEQUENCE AND HOMOLOGS OF THE IVA2, DNA-POLYMERASE AND TERMINAL PROTEINS, Gene, 177(1-2), 1996, pp. 35-41
Authors:
YORK JJ
STROM ADG
CONNICK TE
MCWATERS PG
BOYLE DB
LOWENTHAL JW
Citation: Jj. York et al., IN-VIVO EFFECTS OF CHICKEN MYELOMONOCYTIC GROWTH-FACTOR - DELIVERY VIA A VIRAL VECTOR, The Journal of immunology, 156(8), 1996, pp. 2991-2997
Authors:
HERTIG C
PYE AD
HYATT AD
DAVIS SS
MCWILLIAM SM
HEINE HG
WALKER PJ
BOYLE DB
Citation: C. Hertig et al., VACCINIA VIRUS-EXPRESSED BOVINE EPHEMERAL FEVER VIRUS-G BUT NOT G(NS)GLYCOPROTEIN INDUCES NEUTRALIZING ANTIBODIES AND PROTECTS AGAINST EXPERIMENTAL-INFECTION, Journal of General Virology, 77, 1996, pp. 631-640
Citation: Ia. Ramshaw et al., NOVEL VACCINE STRATEGIES FOR MUCOSAL IMMUNITY USING RECOMBINANT FOWLPOX VIRUSES EXPRESSING CYTOKINE GENES, Journal of cellular biochemistry, 1995, pp. 263-263
Citation: Db. Boyle, DISEASE AND FERTILITY-CONTROL IN WILDLIFE AND FERAL ANIMAL POPULATIONS - OPTIONS FOR VACCINE DELIVERY USING VECTORS, Reproduction, fertility and development, 6(3), 1994, pp. 393-400
Citation: Db. Boyle et Hg. Heine, INFLUENCE OF DOSE AND ROUTE OF INOCULATION ON RESPONSES OF CHICKENS TO RECOMBINANT FOWLPOX VIRUS-VACCINES, Veterinary microbiology, 41(1-2), 1994, pp. 173-181
Citation: Hg. Heine et al., MODIFICATION OF INFECTIOUS BURSAL DISEASE VIRUS-ANTIGEN VP2 FOR CELL-SURFACE LOCATION FAILS TO ENHANCE IMMUNOGENICITY, Virus research, 32(3), 1994, pp. 313-328
Citation: Kh. Leong et al., SELECTIVE INDUCTION OF IMMUNE-RESPONSES BY CYTOKINES COEXPRESSED IN RECOMBINANT FOWLPOX VIRUS, Journal of virology, 68(12), 1994, pp. 8125-8130
Citation: C. Hertig et al., RETROVIRUS-LIKE PARTICLES PRODUCED BY VACCINIA VIRUSES EXPRESSING GAG-PRO-POL REGION GENES OF BOVINE LEUKEMIA-VIRUS, Journal of General Virology, 75, 1994, pp. 2213-2221
Citation: Kh. Leong et al., EXPRESSION OF CYTOKINES BY RECOMBINANT FOWLPOX VIRUS IN MICE - A SAFEAND EFFECTIVE VACCINE STRATEGY, Journal of leukocyte biology, 1993, pp. 42-42
Citation: Hg. Heine et Db. Boyle, INFECTIOUS BURSAL DISEASE VIRUS STRUCTURAL PROTEIN VP2 EXPRESSED BY AFOWLPOX VIRUS RECOMBINANT CONFERS PROTECTION AGAINST DISEASE IN CHICKENS, Archives of virology, 131(3-4), 1993, pp. 277-292